Squarepoint Ops LLC Concert Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$57 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.8 - $6.36 $31,541 - $71,645	11,265 New	11,265 $47,000
Q4 2021 Feb 14, 2022	SELL	$2.69 - $4.22 $73,256 - $114,923	-27,233 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $51,468 - $67,379	-16,236 Reduced 37.35%	27,233 $89,000
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $20,949 - $29,118	5,557 Added 14.66%	43,469 $183,000
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $184,252 - $495,509	37,912 New	37,912 $189,000

Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $193,325 - $261,846	-20,393 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.67 - $10.82 $176,807 - $220,652	20,393 New	20,393 $200,000
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $331,258 - $489,242	-42,469 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $107,986 - $236,379	-18,058 Reduced 29.83%	42,469 $375,000
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $26,682 - $43,085	-4,673 Reduced 7.17%	60,527 $558,000
Q3 2019 Nov 14, 2019	BUY	$5.88 - $12.35 $259,331 - $544,684	44,104 Added 209.06%	65,200 $383,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $29,924 - $41,590	3,170 Added 17.68%	21,096 $253,000
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $216,366 - $314,422	17,926 New	17,926 $216,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $474,750 - $682,374	-42,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.82 - $17.88 $44,870 - $62,580	3,500 Added 9.04%	42,200 $626,000
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $260,259 - $334,950	15,464 Added 66.55%	38,700 $651,000
Q1 2018 May 15, 2018	BUY	$19.24 - $28.03 $76,440 - $111,363	3,973 Added 20.63%	23,236 $532,000
Q4 2017 Feb 14, 2018	SELL	$13.96 - $29.05 $31,228 - $64,984	-2,237 Reduced 10.4%	19,263 $498,000
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $299,065 - $329,165	21,500	21,500 $317,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account